One common misperception about Puerto Rico’s financial woes is that they are the result of the end of Section 936, a law that gave U.S. corporations some tax advantages if they based some part of their company operations in Puerto Rico.
Section 936 provided a tax credit equal to the tax liability of certain kinds of businesses in Puerto Rico. That means that income generated in Puerto Rico could be essentially tax free. In 1992, a report from the Congressional Budget Office calculated that the federal government would lose $15 billion between 1993 and 1997 if the exemptions continued.
The pharmaceuticals industry in particular took advantage of Section 936 in ways that were far from the initial intention of the law, and which didn’t benefit Puerto Rico. The U.S. General Accounting Office (GAO) explained how this could happen in a 1992 report on the pharma industry in Puerto Rico:
A pharmaceutical company would develop a drug in its U.S. research facilities and transfer the drug patent to its wholly owned subsidiary operating in Puerto Rico. The subsidiary would produce the patented drug and claim the income obtained from the drug sales as tax-free income.
In 1982, the law was changed to make it harder for companies to shelter income from “intangibles” such as patents, but the amount of income sheltered continued to outweigh the benefits to Puerto Rico substantially. As the GAO put it in their report, “the average tax revenue lost per job was higher than the average employee compensation paid by section 936 corporations.”
Pharmaceuticals in particular received 267% in tax savings compared with the income they provided for people in Puerto Rico: for every dollar they paid a worker, they saved $2.67 in taxes they would have paid to the federal government. From the point of view of the government, it would have been much less expensive to provide jobs directly to the people hired by the pharma companies in a 1930s-style WPA program. In fact, such a plan could have employed twice as many people and still cost the government significantly less than Section 936 did.
In the 1970s and 1980s, growth in income and property for people living in Puerto Rico increased by 2.3 percent per year. In most recent years, Puerto Rico’s economy has contracted. But in the same 20th century expansion years, the amount of Puerto Rico-based income and property grew for nonresidents by 7.7 percent each year. So the benefits of Section 936, to the extent that they helped grow Puerto Rico’s economy, were primarily felt by the investors, not by the residents of the Island.
And throughout those growth years, unemployment in Puerto Rico remained above 11% and per capita income was significantly lower that that of any state. The GAO reports make it clear that the economic benefit to Puerto Rico of Section 936 was not impressive, though it saved U.S. corporations billions of dollars in taxes. The number of corporations which benefited was small, and all U.S. taxpayers subsidized the savings enjoyed by those companies. The tax provisions which had been intended to lure companies to build factories in Puerto Rico became taxpayer subsidies of companies which did not actually provide job growth on the island.
These tax credits were repealed in 1995 and expired at the end of 2005. A GAO report in 1997 concluded that things were going well for Puerto Rico overall, and found no evidence that the end of Section 936 had been harmful to Puerto Rico’s economy. The report warned that there were many other factors that could affect the economy and did not state that the changes in Section 936 had not been harmful, but no clear indications of harmful effects were identified.
While tax credits can lure businesses to a region, and many states and cities on the U.S. mainland make use of them, corporations will not build businesses in a locality and support the communities with jobs and capital investments just for tax credits. The location must be a good place to do business. Otherwise, corporations will commit themselves to the locality only enough to gain the tax loopholes — and that is not enough to benefit the Island.
Sources:
Yet the dispicable PPD/PDP insists PR cannot survive without a 936 replacement. They also claim statehood will destroy the economy.
The PPD, always doing the dirty work of the “936” companies in Puerto Rico!
Meaning the companies and members of the Liberal Elite today’s PPD were the main beneficiaries, not el jibaro or local professionals while giving the US economy a $15B blow below the belt. Same strategies used by mainland liberal elite.
[…] reference is to Section 936, a tax code which benefited corporations without producing sustainable growth in Puerto […]
[…] reference is to Section 936, a tax code which benefited corporations without producing sustainable growth in Puerto […]
[…] of the proposals for Puerto Rico’s economic recovery plan include programs reminiscent of Section 936 of the Internal Revenue Code, a special tax break for U.S. corporations that located some part of […]
[…] From 1917 onward, interest on Puerto Rican bonds has been tax-free. And in 1976, lawmakers created Section 936 of the IRS Tax Code, which granted U.S.-based corporations a tax exemption on income earned in Puerto Rico. Many firms, […]
[…] aimed at improving Puerto Rico’s economic growth stand in contrast to efforts to revitalize Section 936 of the tax code, which rewarded large corporations based in the States for technically […]
[…] also important to recognize that the end of Section 936 is not the cause the current economic problems, or the high level of unemployment in Puerto Rico. […]
[…] See our previous article about United States General Accounting Office conclusions regarding 936. […]
[…] of the major efforts have been based on tax incentives — including tax incentives that cost the federal government so much that they could have saved money by simply paying the […]
[…] 1976, Congress passed Sec. 936 of the Internal Revenue Code to create a tax credit for U.S.-based manufacturers who brought their […]
[…] referred primarily to poorly paid needlework done as piecework in homes. Later, special tax incentives allowed U.S. corporations to wash profits through Puerto Rico without providing many jobs or a […]
[…] referred primarily to poorly paid needlework done as piecework in homes. Later, special tax incentives allowed U.S. corporations to wash profits through Puerto Rico without providing many jobs or a […]
[…] Rico’s Section 936 was a good example of this phenomenon. It is estimated that pharmaceutical companies operating […]
[…] financial doldrums since 2006. Two years before the US went off the cliff. Congress abolished section 936, a law that gave huge tax breaks to U.S. corporations in Puerto Rico. When it expired at the end of […]
[…] on top of Puerto Rico being in the financial doldrums since 2006 thanks to Congress abolishing section 936 of Puerto Rico’s corporate tax code, a law that gave huge tax breaks to U.S. corporations in […]
[…] Maria and Donald Trump’s offer of aid: paper towels; Section 936 gone awry, austerity measures, #RickyRenuncia followed by #WandaRenuncia, 1500 earthquakes in 40 days, […]
[…] Maria and Donald Trump’s offer of aid: paper towels; Section 936 gone awry, austerity measures, #RickyRenuncia followed by #WandaRenuncia, 1500 earthquakes in 40 days, […]
[…] in force; in fact, during that time income fell from 35% to 32% of the average U.S. income. and the beneficiaries of the law were a handful corporations that sheltered billions in revenue from […]
[…] By 1976, American factories in Puerto Rico were losing their competitive edge to cheaper overseas labor in Africa and Asia and elsewhere in latin America. That’s the year then-New Jersey Senator Bill Bradley slipped Section 936 into the IRS tax code, which gave vast financial incentives and tax breaks to multinational pharmaceutical firms that built factories in Puerto Rico. That created a huge industry in Puerto Rico, which didn’t benefit the locals much but was a boon to the drug lords. “A pharmaceutical company would develop a drug in its US research facilities and transfer the drug patent to its wholly owned subsidiary operating in Puerto Rico,” explained a 1992 report by the General Accounting Office. “The subsidiary would produce the patented drug and claim the income obtained from the drug sales as tax-free income.” For every dollar they paid a worker, the drug firms saved $2.67 in taxes.” […]
[…] phased out. It was profitable for the multinational corporations that took advantage of it, and expensive for the federal government, but it did not benefit Puerto Rico […]